Commitment to Epilepsy Aquestive is a pharmaceutical company that advances and commercializes medicines to solve therapeutic problems and meaningfully improve people's lives. Aquestive has focused on applying its technology to address unmet patient needs in CNS conditions, including epilepsy. The Company's first proprietary commercial product was approved by the FDA for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). The Company is also investigating Libervant™ (diazepam buccal film) as a novel, fast-acting, oral rescue treatment for increased bouts of seizure activity. Advocacy relationships Aquestive works with patient advocacy organizations to gain insights into patient needs; to provide accurate, timely and helpful information on our products; and to identify and improve resources that support patients and caregivers throughout their treatment journey. We know that strong patient communities are an essential lifeline to individual families seeking better care and outcomes. Supporting the Lennox-Gastaut syndrome (LGS) community The Art of Living with LGS is a community art project that was organized by Aquestive as a way to help families with LGS share advice, inspiration, and experiences with others. The event debuted at the 6th International Family and Professional Conference on Lennox-Gastaut syndrome. Together, the LGS community created not just art, but also the picture of a better life for all those living with LGS. The Art of LGS Video Feelings about an LGS diagnosis Feelings about an LGS diagnosis The LGS journey Hopes and wishes for LGS patients Hopes and wishes for LGS patients LGS community partners LGS community partners The LGS journey Feelings about an LGS diagnosis Helping hands and tips The Art of LGS Book The Art of LGS Book People with LGS have another choice for treatment Learn about Sympazan® New product under investigation Learn about Diazepam Buccal Film Contact Us About Us Our Medicines Pipeline Innovative Drug Delivery Collaborations Investors Careers Newsroom Images of individuals were purchased by Aquestive® Therapeutics and are intended to model real patient scenarios. © 2020 Aquestive Therapeutics, Inc. PharmFilm®, Sympazan®, and the Aquestive logo are registered trademarks of Aquestive Therapeutics, Inc. All rights reserved. Terms of Use Privacy Policy Corporate Governance Code of Conduct California Compliance Declaration California Consumer Privacy Policy Sitemap This site uses cookies to store information on your computer. Some are essential to make our site work; others help us improve the user experience. By using the site, you consent to the placement of these cookies. OkLearn More